NANOCAN Trademark

Trademark Overview

On Wednesday, April 22, 2020, a trademark application was filed for NANOCAN with the United States Patent and Trademark Office. The USPTO has given the NANOCAN trademark a serial number of 88883430. The federal status of this trademark filing is REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED as of Saturday, August 24, 2024. This trademark is owned by Nanocan Therapeutics Corporation. The NANOCAN trademark is filed in the Pharmaceutical Products category with the following description:

Biological preparations for the treatment of infectious diseases and cancers; pharmaceutical products for the prevention and treatment of infectious diseases and cancers; transdermal topical patches for medical and therapeutic treatment of infectious diseases and cancers
nanocan

General Information

Serial Number88883430
Word MarkNANOCAN
Filing DateWednesday, April 22, 2020
Status654 - REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED
Status DateSaturday, August 24, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesBiological preparations for the treatment of infectious diseases and cancers; pharmaceutical products for the prevention and treatment of infectious diseases and cancers; transdermal topical patches for medical and therapeutic treatment of infectious diseases and cancers
Pseudo MarkNANO CAN
Translation of Words in MarkThe wording "NANOCAN" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, May 3, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNanocan Therapeutics Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 085406235

Trademark Events

Event DateEvent Description
Saturday, April 25, 2020NEW APPLICATION ENTERED
Sunday, May 3, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 14, 2020ASSIGNED TO EXAMINER
Wednesday, July 15, 2020NON-FINAL ACTION WRITTEN
Wednesday, July 15, 2020NON-FINAL ACTION E-MAILED
Wednesday, July 15, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 23, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 3, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 3, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, November 3, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 3, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 3, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, December 18, 2020ASSIGNED TO LIE
Tuesday, December 22, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 22, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 23, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, January 6, 2021SUSPENSION LETTER WRITTEN
Wednesday, January 6, 2021LETTER OF SUSPENSION E-MAILED
Wednesday, January 6, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, July 6, 2021REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, January 6, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, July 18, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, February 26, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Saturday, August 24, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Saturday, August 26, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

Related Keywords

nanocan cancers infectious diseases treatment topical patches therapeutic transdermal medical pharmaceutical